All Butantan Institute articles
-
NewsResearchers reveals why recombinant BCG induces a stronger and longer-lasting response
Researchers are working on a more potent version of the BCG vaccine that protects against TB. While the conventional immunizer reduced infection by 90% in experiments with mice, the recombinant BCG increased protection rates to 99%.
-
NewsDengue vaccine protects 79.6% of those vaccinated, study shows
The single-dose Butantan-DV dengue vaccine prevents development of the disease in 79.6% of those vaccinated, according to a new study.
